Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Patients With PBC
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
Study to determine the effect of the investigational drug obeticholic acid (also known as
OCA) in combination with the investigational drug bezafibrate (BZF) in patients with Primary
Biliary Cholangitis (also known as PBC).